So far, most studies have mainly focused on the aberrant activation of FGF19–FGFR4 signalling in HCC,8, 9 but the regulation mechanism of FGFR4 expression in tumour progression is still largely unknown. The gene discussed is FGFR4; the disease is neoplasm.